Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea
-
Nadereh Bakhshandeh
, Maryam Mohammadi , Parisa Mohammadi , Elahe Nazari , Mehdi Damchi , Sajad Khodabandelu und Hossein Mokhtari
Abstract
Objectives
Androgen receptor (AR) play a key role in the onset and progression of prostate cancer. Epigallocatechin-3-gallate (EGCG) is a polyphenolic compound and the active ingredient in green tea, which is involved in modulating gene expression through epigenetic alterations. Previous studies have shown that EGCG at low concentrations reduces the expression of AR and prostate-specific antigen (PSA) in the LNCaP cell line of prostate cancer. In this study, the effect of higher EGCG concentrations on AR and PSA expression in LNCaP prostate cancer cell line was investigated.
Methods
In this study, LNCaP prostate cancer cell line was used and after MTT test, concentrations of 40, 60 and 80 μg/mL EGCG were used for treatment. Then, the expression of AR and PSA genes was evaluated by RT-PCR. AR protein expression was also assessed by Western blotting.
Results
The present study showed that treatment of LNCaPs cells by EGCG reduces cell proliferation. The IC50 value was 42.7 μg/mL under experimental conditions. It was also observed that EGCG at concentrations of 40 and 80 μg/mL increased the expression of AR and PSA (p<0.05).
Conclusions
The present study showed that the effect of EGCG on AR expression was different at different concentrations, so that unlike previous studies, higher concentrations of EGCG (80 and 40 μg/mL) increased AR and PSA expression. It seems that due to the toxic effects of EGCG in high concentrations on cancer cells and the possibility of its effect on normal cells, more caution should be exercised in its use.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: Ethical code: TBZmed.REC.1394.618.
References
1. Jemal, A, Siegel, R, Xu, J, Ward, E. Cancer statistics. CA A Cancer J Clin 2010;60:277–300. https://doi.org/10.3322/caac.20073.Suche in Google Scholar PubMed
2. Faskhoudi, MA, Molaei, P, Sadrkhanloo, M, Orouei, S, Hashemi, M, Bokaie, S, et al.. Molecular landscape of c-Myc signaling in prostate cancer: a roadmap to clinical translation. Pathol Res Pract 2022:153851. https://doi.org/10.1016/j.prp.2022.153851.Suche in Google Scholar PubMed
3. Allemailem, KS, Almatroudi, A, Alrumaihi, F, Almansour, NM, Aldakheel, FM, Rather, RA, et al.. Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics. Am J Tourism Res 2021;13:3868.Suche in Google Scholar
4. Ratajczak, W, Lubkowski, M, Lubkowska, A. Heat shock proteins in benign prostatic hyperplasia and prostate cancer. Int J Mol Sci 2022;23:897. https://doi.org/10.3390/ijms23020897.Suche in Google Scholar PubMed PubMed Central
5. Sadrkhanloo, M, Entezari, M, Rashidi, M, Hashemi, M, Raesi, R, Saghari, S, et al.. Non-coding RNAs in EMT regulation: association with tumor progression and therapy response. Eur J Pharmacol 2022;932:175212. https://doi.org/10.1016/j.ejphar.2022.175212.Suche in Google Scholar PubMed
6. Maroufi, NF, Rashidi, M, Vahedian, V, Jahanbazi, R, Mostafaei, S, Akbarzadeh, M, et al.. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line. Breast Cancer 2022;29:260–73. https://doi.org/10.1007/s12282-021-01310-4.Suche in Google Scholar PubMed
7. Vickman, RE, Franco, OE, Moline, DC, Vander Griend, DJ, Thumbikat, P, Hayward, SW. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review. Asian J Urol 2020;7:191–202. https://doi.org/10.1016/j.ajur.2019.10.003.Suche in Google Scholar PubMed PubMed Central
8. Li, D, Zhou, W, Pang, J, Tang, Q, Zhong, B, Shen, C, et al.. A magic drug target: androgen receptor. Med Res Rev 2019;39:1485–514. https://doi.org/10.1002/med.21558.Suche in Google Scholar PubMed
9. Behroozaghdam, M, Dehghani, M, Zabolian, A, Kamali, D, Javanshir, S, Hasani Sadi, F, et al.. Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cell Mol Life Sci 2022;79:1–27. https://doi.org/10.1007/s00018-022-04551-4.Suche in Google Scholar PubMed
10. Rashidi, M, Mahmoudian, E, Mirzaei, S, Mazloomi, SN, Bazi, A, Azadeh, H, et al.. Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro. Chem Biol Interact 2022;365:110087. https://doi.org/10.1016/j.cbi.2022.110087.Suche in Google Scholar PubMed
11. Hashemi, M, Mirzaei, S, Barati, M, Hejazi, ES, Kakavand, A, Entezari, M, et al.. Curcumin in the treatment of urological cancers: therapeutic targets, challenges and prospects. Life Sci 2022:120984.10.1016/j.lfs.2022.120984Suche in Google Scholar PubMed
12. Bastani, S, Vahedian, V, Rashidi, M, Mir, A, Mirzaei, S, Alipourfard, I, et al.. An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin. Biomed Pharmacother 2022;153:113297. https://doi.org/10.1016/j.biopha.2022.113297.Suche in Google Scholar PubMed
13. Shiran, MR, Mahmoudian, E, Ajami, A, Hosseini, SM, Khojasteh, A, Rashidi, M, et al.. Effect of Auraptene on angiogenesis in Xenograft model of breast cancer. Horm Mol Biol Clin Invest 2022;43:7–14. https://doi.org/10.1515/hmbci-2021-0056.Suche in Google Scholar PubMed
14. Sabzichi, M, Oladpour, O, Mohammadian, J, Rashidi, M, Hosseinzadeh, M, Mardomi, A, et al.. Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells. N Schmied Arch Pharmacol 2021;394:2429–39. https://doi.org/10.1007/s00210-021-02164-5.Suche in Google Scholar PubMed
15. Ahmadian, S, Sabzichi, M, Rashidi, M, Mohammadian, J, Mahmoudi, S, Maroufi, NF, et al.. Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism. N Schmied Arch Pharmacol 2021;394:1521–8. https://doi.org/10.1007/s00210-021-02079-1.Suche in Google Scholar PubMed
16. Vahedian, V, Asadi, A, Esmaeili, P, Zamani, S, Zamani, R, Hajazimian, S, et al.. Anti-inflammatory activity of emu oil-based nanofibrous scaffold through downregulation of IL-1, IL-6, and TNF-α pro-inflammatory cytokines. Horm Mol Biol Clin Invest 2020;41:20190052. https://doi.org/10.1515/hmbci-2019-0052.Suche in Google Scholar PubMed
17. Mohammadian, J, Mahmoudi, S, Pourmohammad, P, Pirouzpanah, M, Salehnia, F, Maroufi, NF, et al.. Formulation of Static as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells. N Schmied Arch Pharmacol 2020;393:2315–23. https://doi.org/10.1007/s00210-020-01942-x.Suche in Google Scholar PubMed
18. Samynathan, R, Thiruvengadam, M, Nile, SH, Shariati, MA, Rebezov, M, Mishra, RK, et al.. Recent insights on tea metabolites, their biosynthesis and chemo-preventing effects: a review. Crit Rev Food Sci Nutr 2021:1–20. https://doi.org/10.1080/10408398.2021.1984871.Suche in Google Scholar PubMed
19. Wang, S, Li, Z, Ma, Y, Liu, Y, Lin, C-C, Li, S, et al.. Immunomodulatory effects of green tea polyphenols. Molecules 2021;26:3755. https://doi.org/10.3390/molecules26123755.Suche in Google Scholar PubMed PubMed Central
20. Hayakawa, S, Ohishi, T, Miyoshi, N, Oishi, Y, Nakamura, Y, Isemura, M. Anti-cancer effects of green tea epigallocatchin-3-gallate and coffee chlorogenic acid. Molecules 2020;25:4553. https://doi.org/10.3390/molecules25194553.Suche in Google Scholar PubMed PubMed Central
21. Chen, B-H, Hsieh, C-H, Tsai, S-Y, Wang, C-Y, Wang, C-C. Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway. Sci Rep 2020;10:1–11. https://doi.org/10.1038/s41598-020-62136-2.Suche in Google Scholar PubMed PubMed Central
22. Gan, R-Y, Li, H-B, Sui, Z-Q, Corke, H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review. Crit Rev Food Sci Nutr 2018;58:924–41. https://doi.org/10.1080/10408398.2016.1231168.Suche in Google Scholar PubMed
23. Fathi Maroufi, N, Taefehshokr, S, Rashidi, M-R, Taefehshokr, N, Khoshakhlagh, M, Isazadeh, A, et al.. Vascular mimicry: changing the therapeutic paradigms in cancer. Mol Biol Rep 2020;47:4749–65. https://doi.org/10.1007/s11033-020-05515-2.Suche in Google Scholar PubMed
24. Haiaty, S, Rashidi, MR, Akbarzadeh, M, Maroufi, NF, Yousefi, B, Nouri, M. Targeting vasculogenic mimicry by phytochemicals: a potential opportunity for cancer therapy. IUBMB Life 2020;72:825–41. https://doi.org/10.1002/iub.2233.Suche in Google Scholar PubMed
25. Pourmohammad, P, Maroufi, NF, Rashidi, M, Vahedian, V, Pouremamali, F, Faridvand, Y, et al.. Potential therapeutic effects of melatonin mediate via miRNAs in cancer. Biochem Genet 2021:1–23. https://doi.org/10.1007/s10528-021-10104-4.Suche in Google Scholar PubMed
26. Asefy, Z, Tanomand, A, Hoseinnejhad, S, Ceferov, Z, Oshaghi, EA, Rashidi, M. Unsaturated fatty acids as a co-therapeutic agents in cancer treatment. Mol Biol Rep 2021;48:2909–16. https://doi.org/10.1007/s11033-021-06319-8.Suche in Google Scholar PubMed
27. Kalantar, H, Rashidi, M, Kalantar, M, Tavallaei, M, Hosseini, SM. Anticancer effects of valproic acid via regulation of epigenetic mechanisms in non-small-cell lung cancer A549 cell line. Iran J Pharm Res (IJPR): IJPR 2021;20:133.Suche in Google Scholar
28. Rashidi, M, Bazi, A, Shiran, MR, Bagheri, A, Mehrabadi, AR, Kalantar, H, et al.. Tropisetron attenuates tumor growth and progression in an experimental model of mouse lung cancer. J Cell Biochem 2020;121:1610–22. https://doi.org/10.1002/jcb.29395.Suche in Google Scholar PubMed
29. Rashidi, M, Khalilnezhad, A, Amani, D, Jamshidi, H, Muhammadnejad, A, Bazi, A, et al.. Umbelliprenin shows antitumor, antiangiogenesis, antimetastatic, anti-inflammatory, and immunostimulatory activities in 4T1 tumor-bearing Balb/c mice. J Cell Physiol 2018;233:8908–18. https://doi.org/10.1002/jcp.26814.Suche in Google Scholar PubMed
30. Alizadeh, MN, Rashidi, M, Muhammadnejad, A, Zanjani, TM, Ziai, SA. Antitumor effects of umbelliprenin in a mouse model of colorectal cancer. Iran J Pharm Res (IJPR): IJPR 2018;17:976.Suche in Google Scholar
31. Hajipour, H, Hamishehkar, H, Soltan Ahmad, NS, Barghi, S, Maroufi, NF, Taheri, RA. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers. Artif Cell Nanomed Biotechnol 2018;46:283–92. https://doi.org/10.1080/21691401.2017.1423493.Suche in Google Scholar PubMed
32. Tsukamoto, S, Hirotsu, K, Kumazoe, M, Goto, Y, Sugihara, K, Suda, T, et al.. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. Biochem J 2012;443:525–34. https://doi.org/10.1042/bj20111837.Suche in Google Scholar PubMed
33. Amani, D, Shakiba, E, Motaghi, E, Alipanah, H, Jalalpourroodsari, M, Rashidi, M. Psoralidin exerts anti-tumor, anti-angiogenic, and immunostimulatory activities in 4T1 tumor-bearing balb/c mice. Horm Mol Biol Clin Invest 2022;43:71–9. https://doi.org/10.1515/hmbci-2021-0028.Suche in Google Scholar PubMed
34. Bettuzzi, S, Brausi, M, Rizzi, F, Castagnetti, G, Peracchia, G, Corti, A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006;66:1234–40. https://doi.org/10.1158/0008-5472.can-05-1145.Suche in Google Scholar PubMed
35. Brausi, M, Rizzi, F, Bettuzzi, S. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol 2008;54:472–3. https://doi.org/10.1016/j.eururo.2008.03.100.Suche in Google Scholar PubMed
36. Chow, HS, Cai, Y, Alberts, DS, Hakim, I, Dorr, R, Shahi, F, et al.. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon. E. Cancer Epidemiology Biomarkers & Prevention 2001;10:53–8.Suche in Google Scholar
37. Pezzato, E, Sartor, L, Dell’Aica, I, Dittadi, R, Gion, M, Belluco, C, et al.. Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (−)epigallocatechin-3-gallate. Int J Cancer 2004;112:787–92. https://doi.org/10.1002/ijc.20460.Suche in Google Scholar PubMed
38. Zhou, Y-D, Kim, Y-P, Li, X-C, Baerson, SR, Agarwal, AK, Hodges, TW, et al.. Hypoxia-inducible factor-1 activation by (−)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J Nat Prod 2004;67:2063–9. https://doi.org/10.1021/np040140c.Suche in Google Scholar PubMed PubMed Central
39. Maroufi, NF, Amiri, M, Dizaji, BF, Vahedian, V, Akbarzadeh, M, Roshanravan, N, et al.. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. Eur J Pharmacol 2020;881:173282. https://doi.org/10.1016/j.ejphar.2020.173282.Suche in Google Scholar PubMed
40. Siddiqui, IA, Asim, M, Hafeez, BB, Adhami, VM, Tarapore, RS, Mukhtar, H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. Faseb J 2011;25:1198–207. https://doi.org/10.1096/fj.10-167924.Suche in Google Scholar PubMed PubMed Central
41. Bushman, JL. Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998;31:151–9. https://doi.org/10.1080/01635589809514697.Suche in Google Scholar PubMed
42. Lee, M-J, Wang, Z-Y, Li, H, Chen, L, Sun, Y, Gobbo, S, et al.. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiology and Prevention Biomarkers 1995;4:393–9.Suche in Google Scholar
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Letter to the Editor
- The role of gut microbiota in etiopathogenesis of long COVID syndrome
- Original Articles
- Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI)
- Association of pro-inflammatory cytokines, inflammatory proteins with atherosclerosis index in obese male subjects
- Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters
- Distinct urinary progesterone metabolite profiles during the luteal phase
- Promoter methylation levels of RASSF1 and ATIC genes are associated with lung cancer in Iranian patients
- Population status of selenium in Colombia and associated factors: a cross-sectional study
- Bambusa vulgaris leaves reverse mitochondria dysfunction in diabetic rats through modulation of mitochondria biogenic genes
- Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea
- The effects of endurance exercise and metformin on memory impairment caused by diabetes
- Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease
- The effect of co-administration of artemisinin and N-acetyl cysteine on antioxidant status, spermatological parameters and histopathology of testis in adult male mice
- Case Report
- Unilateral ovarian agenesis with ipsilateral tubal presence – report of a case
- Review Articles
- Brown adipose tissue as an endocrine organ: updates on the emerging role of batokines
- Zuranolone and its role in treating major depressive disorder: a narrative review
Artikel in diesem Heft
- Frontmatter
- Letter to the Editor
- The role of gut microbiota in etiopathogenesis of long COVID syndrome
- Original Articles
- Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI)
- Association of pro-inflammatory cytokines, inflammatory proteins with atherosclerosis index in obese male subjects
- Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters
- Distinct urinary progesterone metabolite profiles during the luteal phase
- Promoter methylation levels of RASSF1 and ATIC genes are associated with lung cancer in Iranian patients
- Population status of selenium in Colombia and associated factors: a cross-sectional study
- Bambusa vulgaris leaves reverse mitochondria dysfunction in diabetic rats through modulation of mitochondria biogenic genes
- Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea
- The effects of endurance exercise and metformin on memory impairment caused by diabetes
- Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease
- The effect of co-administration of artemisinin and N-acetyl cysteine on antioxidant status, spermatological parameters and histopathology of testis in adult male mice
- Case Report
- Unilateral ovarian agenesis with ipsilateral tubal presence – report of a case
- Review Articles
- Brown adipose tissue as an endocrine organ: updates on the emerging role of batokines
- Zuranolone and its role in treating major depressive disorder: a narrative review